Page last updated: 2024-10-30

labetalol and Nearsightedness

labetalol has been researched along with Nearsightedness in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"In order to normalize the condition of pseudomyopia, the following can be summarized: One percent cyclopentolate was effective in 63%, and 0."5.06Myopia prevention and therapy. The role of pharmaceutical agents. Japanese studies. ( Hosaka, A, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hosaka, A1

Trials

1 trial available for labetalol and Nearsightedness

ArticleYear
Myopia prevention and therapy. The role of pharmaceutical agents. Japanese studies.
    Acta ophthalmologica. Supplement, 1988, Volume: 185

    Topics: Adolescent; Child; Cyclopentolate; Humans; Labetalol; Myopia; Ophthalmic Solutions; Timolol; Tropica

1988